Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines

Published:2019-07-31 Issue:4 Volume:84 Page:771-780
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Min Dong-Joon,Zhao Yingdong,Monks Anne,Palmisano Alida,Hose Curtis,Teicher Beverly A.,Doroshow James H.,Simon Richard M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-019-03898-z.pdf

Reference66 articles.

1. Moysan E, Bastiat G, Benoit JP (2013) Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modifications. Mol Pharm 10(2):430–444. https://doi.org/10.1021/mp300370t

2. Swift LH, Golsteyn RM (2014) Genotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cells. Int J Mol Sci 15(3):3403–3431. https://doi.org/10.3390/ijms15033403

3. Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Minchin RF, Guminski A (2012) Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO Mol Med 4(8):675–684. https://doi.org/10.1002/emmm.201101131

4. Turner NC, Reis-Filho JS (2012) Genetic heterogeneity and cancer drug resistance. Lancet Oncol 13(4):e178–e185. https://doi.org/10.1016/S1470-2045(11)70335-7

5. Eckstein N (2011) Platinum resistance in breast and ovarian cancer cell lines. J Exp Clin Cancer Res 30:91. https://doi.org/10.1186/1756-9966-30-91

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated biomarker responses: Unveiling insights through serum biochemistry, oxidative stress, genotoxicity and histopathology;Biomarkers in Environmental and Human Health Biomonitoring;2024

2. Genomics-based tools for drug discovery and development: From network maps to efficacy prediction;Journal of Holistic Integrative Pharmacy;2023-11

3. Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines;International Journal of Molecular Sciences;2023-03-16

4. USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma;Oncogene;2022-10-15

5. TPWshiny: an interactive R/Shiny app to explore cell line transcriptional responses to anti-cancer drugs;Bioinformatics;2021-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3